Mine the Graveyard: How Abandoned Drug Patents and Unclaimed Chemical Space Become Your Competitor’s Next Blockbuster
In the spring of 2014, a small biotech called Idenix Pharmaceuticals held patents covering certain nucleotide analogue structures with antiviral […]









